UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Alburex 200 g/l Infusionsvätska, lösning
- Invented Name Part: Alburex
- Strength part: 200 g/l
- Pharmaceutical dose form part: Infusionsvätska, lösning
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: solution for infusion
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 50243
Region: Kingdom of Sweden
Marketing authorisation holder: CSL Behring GmBH
Identifier:
Status: Valid (2014-03-28)
Package 1 of 1
PCID:
Description: Injektionsflaska, 100 ml
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 1 Vial (Glass type II)
Containing: 100 Millilitre(s)
Manufactured Item
Dose form: solution for infusion
Unit of presentation: vial
Ingredient
Role: Active
Substance: human serum albumin
Concentration strength: 200 gram(s) / 1 litre(s)
Reference strength: human serum albumin 200 gram(s) / 1 litre(s)
Administrable Product (1 of 1)
Dose form: solution for infusion
Unit of presentation:
Route of administration:
Ingredient
Role: Active
Substance: human serum albumin
Concentration strength: 200 gram(s) / 1 litre(s)
Reference strength: human serum albumin 200 gram(s) / 1 litre(s)